Inactive Instrument

Insiders NeoGenomics, Inc. OTC Bulletin Board

Equities

US64049M2098

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

05-28	NeoGenomics, Inc. to Introduce Comprehensive Lung Solution & Feature Hematopathology Services At ASCO	CI
05-02	North American Morning Briefing : Stock Futures -3-	DJ

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NeoGenomics, Inc. Announces Senior Leadership Promotions	04-18	CI
NeoGenomics, Inc. Announces Eliminates of Position of Vishal Sikri, President, Advanced Diagnostics	04-18	CI
Invitae Names David Sholehvar Chief Operating Officer	19/10/23	MT
NeoGenomics, Inc. Announces Resignation of Rachel Stahler from Board of Directors	29/06/23	CI
NeoGenomics, Inc. Expands Board of Directors with Appointments of Three Independent Directors	29/06/23	CI
Weaker-than-Expected Skyworks Earnings Outlook Drags Exchange-Traded Funds, Equity Futures Lower Pre-Bell	09/05/23	MT
Neogenomics, Inc. Announces Resignation of David J. Daly to Board of Directors	23/01/23	CI
NeoGenomics Appoints Jeffrey Sherman Chief Financial Officer	06/12/22	MT
NeoGenomics, Inc. Appoints Melody Harris as President, Enterprise Operations effective December 5, 2022	18/11/22	CI
NeoGenomics Appoints David Perez to its Board of Directors	07/11/22	CI
NeoGenomics, Inc. Appoints Chris Smith as Chief Executive Officer, Effective August 15, 2022	21/07/22	CI
NeoGenomics, Inc. Appoints Chris Smith as Member of the Board of Directors, Effective August 15, 2022	21/07/22	CI
NeoGenomics Appoints Chris Smith as Chief Executive Starting Aug. 15	21/07/22	MT
NeoGenomics, Inc. Announces Resignation of Douglas Brown as Chief Strategy and Corporate Development Officer	16/05/22	CI
NeoGenomics Appoints Lynn Tetrault as Interim CEO and Board Chair	16/05/22	MT
NeoGenomics Appoints Vishal Sikri as President	11/05/22	MT
Neogenomics, Inc. Announces Executive Changes, Effective May 23, 2022	09/05/22	CI
NeoGenomics, Inc. Announces Executive Changes	06/05/22	CI
NeoGenomics Says CEO Mallon Leaving, Sees Q1 Results Below Guidance -- Stock Sinks 21% After-Hours	28/03/22	MT
NeoGenomics, Inc. Announces Management Changes	28/03/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders NeoGenomics, Inc. OTC Bulletin Board

Equities

US64049M2098

Insiders

Filters